Home › NCT00730678

Pharmacogenetic Determinants Of Treatment Response In Children

Who can join

All ages · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Any patients under evaluation/treatment at St. Jude Children's Research Hospital (SJCRH)
* Parents or family members of St. Jude patients
* Non patient volunteers
* All study subjects must provide informed consent for participation
* Assent/Consent of the patient (parent) must be provided prior to attempts made by investigators to enroll a family member of a SJCRH patient

Exclusion Criteria:

About the study

To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.

Sponsor: St. Jude Children's Research Hospital · Participants: 8,800 · Started: Aug 17, 1998

Contact the study team

• Jun J. Yang, Ph. D. · Phone: 888-226-4343

Official record on ClinicalTrials.gov — NCT00730678

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.